Sarah Gheuens
Fortune : 2 M $ au 31/07/2026
Fortune : 2 M $ au 31/07/2026
Sarah Gheuens is currently an Independent Director at Viridian Therapeutics, Inc. since 2023 and Chief Medical Officer, Head-Research & Development at Agios Pharmaceuticals, Inc. since 2022.
Formerly, Dr. Gheuens was Executive Medical Director at Biogen, Inc. from 2012 to 2019.
Education includes doctorates from Vrije Universiteit Brussel and the University of Antwerp, and graduate studies at Harvard Medical School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/08/2026 | 54 645 ( 0,09% ) | 2 M $ | 31/07/2026 | |
| 01/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2021 |
| VIRIDIAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 25/09/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Directeur Technique/Scientifique/R&D | 01/12/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Vrije Universiteit Brussel
Vrije Universiteit Brussel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Antwerp
University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national